<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780819/" ref="ordinalpos=1847&amp;ncbi_uid=2153238&amp;link_uid=PMC2780819" image-link="/pmc/articles/PMC2780819/figure/F3/" class="imagepopup">Fig. (3).  From: Roles of IL-6-gp130 <span class="highlight" style="background-color:">Signaling</span> in Vascular Inflammation. </a></div><br /><div class="p4l_captionBody"><b>Negative regulation of the JAK-STAT pathway.</b> Shown are the major negative autoregulatory pathways of IL-6 induced STAT3 signaling. IL-6 activated STAT3 both engages the suppressor of cytokine signaling (SOCS3) gene, inducing its expression and recruits SOC3 to gp130 where it subsequently terminates STAT3 activation via JAK1 inactivation. SHP2 phosphatase activity also inactivates gp130 and JAKs.</div></div>